Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
- 20/10/2024, 22:47
-
ansa.it
0
Scopri altro
- ieri, 17:08
-
repubblica.it
-
0
- 20/12/2024, 21:47
-
ansa.it
-
0
- 20/12/2024, 21:39
-
ansa.it
-
0
- 20/12/2024, 21:30
-
ansa.it
-
0
- 20/12/2024, 21:09
-
ansa.it
-
0
- 20/12/2024, 21:09
-
ansa.it
-
0
- 20/12/2024, 20:35
-
ansa.it
-
0
- 20/12/2024, 20:19
-
ansa.it
-
0
Nessun commento